Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn’s Disease: A Post Hoc Analysis From the CALM Study
Sign Up to like & getrecommendations! Published in 2020 at "Inflammatory Bowel Diseases"
DOI: 10.1093/ibd/izaa025
Abstract: Abstract Background CALM was a randomized phase 3 trial in patients with Crohn’s disease (CD) that demonstrated improved endoscopic outcomes when treatment was escalated based on cutoffs for inflammatory biomarkers, fecal calprotectin (FC), C-reactive protein… read more here.
Keywords: endoscopic outcomes; post hoc; hoc analysis; disease ... See more keywords